Literature DB >> 3929396

Selection of highly transfectable variant from mouse mastocytoma P815.

A Van Pel, E De Plaen, T Boon.   

Abstract

A tk- cell line derived from mouse mastocytoma P815 was transfected with a plasmid carrying a thymidine kinase gene. The tk+ cells were obtained at a frequency of 10(-6). From some of these tk+ transfectants it was possible to select tk- cells with BrdU so that these cells could be submitted again to transfection with the thymidine kinase gene. By repeating cycles of transfection and tk+ selection followed by reverse selection with BrdU, it was possible to obtain a stable variant having a 100-fold increase in transfection efficiency. This HTR (high transfection) variant shows a high efficiency of transfection (10(-4)) for the neomycin-resistance gene as well as for the thymidine kinase gene.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929396     DOI: 10.1007/bf01534840

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  32 in total

1.  A new approach to the cloning of genes encoding T-cell epitopes.

Authors:  D M Scott; P J Dyson; E Simpson
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.

Authors:  Hiroyoshi Nishikawa; Eiichi Sato; Gabriel Briones; Li-Mei Chen; Mitsutoshi Matsuo; Yasuhiro Nagata; Gerd Ritter; Elke Jäger; Hideki Nomura; Shigeto Kondo; Isao Tawara; Takuma Kato; Hiroshi Shiku; Lloyd J Old; Jorge E Galán; Sacha Gnjatic
Journal:  J Clin Invest       Date:  2006-06-22       Impact factor: 14.808

3.  DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows identification of residues involved in epitopes recognized by antibodies and T cells.

Authors:  E P Cowan; M L Jelachich; W E Biddison; J E Coligan
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 4.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Authors:  Pierre G Coulie; Benoît J Van den Eynde; Pierre van der Bruggen; Thierry Boon
Journal:  Nat Rev Cancer       Date:  2014-02       Impact factor: 60.716

5.  Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.

Authors:  T Wölfel; A Van Pel; E De Plaen; C Lurquin; J L Maryanski; T Boon
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells.

Authors:  P M Taylor; J Davey; K Howland; J B Rothbard; B A Askonas
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  Site-directed mutagenesis of an HLA-A3 gene identifies amino acid 152 as crucial for major-histocompatibility-complex-restricted and alloreactive cytotoxic-T-lymphocyte recognition.

Authors:  E P Cowan; M L Jelachich; J E Coligan; W E Biddison
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma.

Authors:  H Ikeda; N Ohta; K Furukawa; H Miyazaki; L Wang; K Kuribayashi; L J Old; H Shiku
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

9.  Reduced lysis by CD8+ cytotoxic T cells in mixed lymphocyte reactions induced via CD4+ T cells exposed to chemically modified antigen presenting cells.

Authors:  L Corlett; D H Davies
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

10.  Efficient expression of tum- antigen P91A by transfected subgenic fragments.

Authors:  P Chomez; E De Plaen; A Van Pel; C De Smet; J P Szikora; C Lurquin; A M Lebacq-Verheyden; T Boon
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.